2-Bromopyrimidine → 6-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-1-(pyrimidin-2-yloxy)-1H-pyrrolo[3,2-b]pyridine
Reaction equation
[OH:1][N:2]1[C:10]2[C:5](=[N:6][CH:7]=[C:8]([C:11]3[CH:12]=[N:13][N:14]([CH:16]4[CH2:21][CH2:20][N:19](C(OC(C)(C)C)=O)[CH2:18][CH2:17]4)[CH:15]=3)[CH:9]=2)[CH:4]=[CH:3]1.Br[C:30]1[N:35]=[CH:34][CH:33]=[CH:32][N:31]=1>>[NH:19]1[CH2:20][CH2:21][CH:16]([N:14]2[CH:15]=[C:11]([C:8]3[CH:9]=[C:10]4[N:2]([O:1][C:30]5[N:35]=[CH:34][CH:33]=[CH:32][N:31]=5)[CH:3]=[CH:4][C:5]4=[N:6][CH:7]=3)[CH:12]=[N:13]2)[CH2:17][CH2:18]1Participants
3
Procedure
The entitled compound is prepared from tert-butyl 4-[4-(1-hydroxy-1H-pyrrolo[3,2-b]pyridin-6-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate and 2-bromo-pyrimidine as described in the last 2 steps of Example 18.
Sources & evidence
- ORD record
- ord-6d5d63ec183c40bf9c679d8eac4d5936
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08912330B2
Reaction notes
Loading…